VAERS reports by lot

Pfizer COVID-19 lot NA0587: VAERS reports

61 VAERS reports list lot NA0587 as a Pfizer COVID-19 vaccine, received between 2025-09-08 and 2026-04-27. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
3%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5832%
Neurological3318%
Musculoskeletal2614%
General / Systemic (non-local)2413%
Cardiac / Cardiovascular116%
Respiratory95%
Allergic / Anaphylactic84%
Dermatological (non-injection-site)84%
Gastrointestinal53%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California10
Minnesota4
New York4
Louisiana4
Texas3
Indiana2
North Carolina2
Arizona2
Kansas2
Virginia2
Massachusetts2
Wisconsin2

Reports by month received

MonthReportsBar
2025-0918
2025-1030
2025-116
2025-122
2026-022
2026-031
2026-042

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): MY9547 · MY9548 · MY9550 · NA0589 · NA0590 · NA0738

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.